Year Published
- 2008 (0)
- 2009 (0)
- 2010 (4) Apply 2010 filter
- 2011 (1) Apply 2011 filter
- 2012 (0)
- 2013 (0)
- 2014 (0)
- 2015 (0)
- (-) Remove 2016 filter 2016
- 2017 (2) Apply 2017 filter
- 2018 (0)
- (-) Remove 2019 filter 2019
- 2020 (0)
- 2021 (0)
Research Topics
Populations
- Countries/Governments (0)
- Rural Populations (0)
- Smallholder Farmers (1) Apply Smallholder Farmers filter
- Women (0)
Types of Research
- (-) Remove Data Analysis filter Data Analysis
- (-) Remove Literature Review filter Literature Review
- (-) Remove Portfolio Review filter Portfolio Review
- Research Brief (0)
Geography
- East Africa Region and Selected Countries (1) Apply East Africa Region and Selected Countries filter
- Global (1) Apply Global filter
- South Asia Region and Selected Countries (0)
- Southern Africa Region and Selected Countries (0)
- Sub-Saharan Africa (0)
- West Africa Region and Selected Countries (0)
Dataset
Current search
- (-) Remove Food Security & Nutrition filter Food Security & Nutrition
- (-) Remove FAOSTAT filter FAOSTAT
- (-) Remove Other Datasets filter Other Datasets
- (-) Remove Literature Review filter Literature Review
- (-) Remove Portfolio Review filter Portfolio Review
- (-) Remove Research & Development filter Research & Development
- (-) Remove Environment & Climate Change filter Environment & Climate Change
- (-) Remove 2016 filter 2016
- (-) Remove Data Analysis filter Data Analysis
- (-) Remove Risk, Preferences, & Decision-Making filter Risk, Preferences, & Decision-Making
- (-) Remove 2019 filter 2019
Studies of improved seed adoption in developing countries almost always draw from household surveys and are premised on the assumption that farmers are able to self-report their use of improved seed varieties. However, recent studies suggest that farmers’ reports of the seed varieties planted, or even whether seed is local or improved, are sometimes inconsistent with the results of DNA fingerprinting of farmers' crops. We use household survey data from Tanzania to test the alignment between farmer-reported and DNA-identified maize seed types planted in fields. In the sample, 70% of maize seed observations are correctly reported as local or improved, while 16% are type I errors (falsely reported as improved) and 14% are type II errors (falsely reported as local). Type I errors are more likely to have been sourced from other farmers, rather than formal channels. An analysis of input use, including seed, fertilizer, and labor allocations, reveals that farmers tend to treat improved maize differently, depending on whether they correctly perceive it as improved. This suggests that errors in farmers' seed type awareness may translate into suboptimal management practices. In econometric analysis, the measured yield benefit of improved seed use is smaller in magnitude with a DNA-derived categorization, as compared with farmer reports. The greatest yield benefit is with correctly identified improved seed. This indicates that investments in farmers' access to information, seed labeling, and seed system oversight are needed to complement investments in seed variety development.
This research considers how public good characteristics of different types of research and development (R&D) and the motivations of different providers of R&D funding affect the relative advantages of alternative funding sources. We summarize the public good characteristics of R&D for agriculture in general and for commodity and subsistence crops in particular, as well as R&D for health in general and for neglected diseases in particular, with a focus on Sub-Saharan Africa and South Asia. Finally, we present rationales for which funders are predicted to fund which R&D types based on these funder and R&D characteristics. We then compile available statistics on funding for agricultural and health R&D from private, public and philanthropic sources, and compare trends in funding from these sources against expectations. We find private agricultural R&D spending focuses on commodity crops (as expected). However contrary to expectations we find public and philanthropic spending also goes largely towards these same crops rather than staples not targeted by private funds. For health R&D private funders similarly concentrate on diseases with higher potential financial returns. However unlike in agricultural R&D, in health R&D we observe some specialization across funders – especially for neglected diseases R&D - consistent with funders’ expected relative advantages.